Genitourinary Symptoms With Levonorgestrel Releasing Intrauterine Systems
NCT01730300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2013-05-15
Summary
The main purpose of the study was to evaluate the efficacy of Levonorgestrel Releasing Intrauterine devices (LNR-IUD) on genitourinary symptoms in patients with abnormal uterine bleeding. The patients were asked urogenital distress inventory (UDI) (which includes; irritative symptoms, stress symptoms, obstructive discomfort) and incontinence impact questionnaire (IIQ) (which includes; physical activity, travel, social/relationships, emotional health)questionnaires in the day of application LNR-IUD and six months later this procedure. Statistical analyse will be performed to evaluate the changes in this time period.
Conditions
- Lower Urinary Tract Symptoms
Sponsors & Collaborators
-
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
lead OTHER_GOV
Principal Investigators
-
Murat Ekin, M.D. · Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology
-
Cihan Kaya, M.D. · Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology
-
Mehmet E Ayag, M.D. · Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology
Eligibility
- Min Age
- 15 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2013-01-31
- Completion
- 2013-05-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis
NCT00823030 ·Status: WITHDRAWN ·Phase: NA
-
Lower Urinary Tract Symptoms Screening Questionnaire
NCT01616810 ·Status: COMPLETED
-
Bladder Shaper Test
NCT04017000 ·Status: COMPLETED ·Phase: NA
-
Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy
NCT03633994 ·Status: UNKNOWN ·Phase: PHASE2
-
Emotional Urinary Tract Infection
NCT07191041 ·Status: NOT_YET_RECRUITING
-
Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis
NCT00275379 ·Status: WITHDRAWN ·Phase: NA
-
Low-dose Naltrexone for Bladder Pain Syndrome
NCT04450316 ·Status: SUSPENDED ·Phase: PHASE2
-
Developing a PROM for Recurrent Urinary Tract Infection
NCT05086900 ·Status: UNKNOWN
-
Evaluating UTI Diagnosis in Nursing Homes
NCT04815369 ·Status: WITHDRAWN
-
Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study
NCT03808038 ·Status: COMPLETED
-
Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections
NCT04285320 ·Status: UNKNOWN ·Phase: PHASE4
-
Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery
NCT06852248 ·Status: RECRUITING
-
Treatment and/or Prevention of Urinary Tract Infections
NCT00801021 ·Status: COMPLETED ·Phase: PHASE1
-
Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections
NCT04305808 ·Status: RECRUITING
-
Painless Laser Therapy for Overactive Bladder
NCT01569061 ·Status: UNKNOWN ·Phase: NA
-
Sensory Sensitivity and Urinary Symptoms in the Female Population
NCT01978002 ·Status: COMPLETED
-
Intravesical Gentamicin to Prevent Recurrent UTI
NCT06332781 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Satisfaction and Long-term Safety of Intravesical Aminoglycoside Instillations in UTI Prevention
NCT05376670 ·Status: COMPLETED
-
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
NCT00775281 ·Status: COMPLETED
-
Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis
NCT04696666 ·Status: UNKNOWN ·Phase: NA
-
Sacral Neuromodulation in Patients With IC
NCT00590473 ·Status: COMPLETED ·Phase: NA
-
The Female Microbiome in Patients Undergoing Bladder Instillation Therapy
NCT05414305 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic and Histopathologic Characteristics of Interstitial Cystitis
NCT03523559 ·Status: COMPLETED
-
Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women
NCT04619238 ·Status: COMPLETED
-
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
NCT01475253 ·Status: TERMINATED ·Phase: PHASE2